Resultados de la búsqueda 1721-1730 of 8086 for alcohol menopause

1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.

2. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. As the global epidemic of obesity and diabetes mellitus spreads, an exponential rise in incident chronic kidney disease (CKD) complicated by ...

3. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...

4. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.

5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Scottsdale/Phoenix, Ariz. The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) ...

7. Estar en forma - Mayo Clinic

   News · agosto 2024 · julio 2024 · junio 2024 · mayo 2024 · febrero 2024 · enero 2024 · diciembre 2023 · septiembre 2023.

8. Hematología - Ensayos clínicos - Mayo Clinic

   Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the growth ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...